- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/26 - Dibenz [b, f] azepinesHydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
Patent holdings for IPC class C07D 223/26
Total number of patents in this class: 41
10-year publication summary
3
|
5
|
2
|
2
|
6
|
2
|
4
|
1
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Crius Technology Group, Inc. | 20 |
11 |
Merck Patent GmbH | 5867 |
4 |
NGK Insulators, Ltd. | 4798 |
3 |
Icahn School of Medicine at Mount Sinai | 910 |
3 |
FUJIFILM Corporation | 28873 |
2 |
Life Technologies Corporation | 3239 |
2 |
Avantium Holding B.V. | 9 |
1 |
Emory University | 1594 |
1 |
EnVivo Pharmaceuticals, Inc. | 30 |
1 |
F.I.S. Fabbrica Italiana Sintetici S.p.A. | 126 |
1 |
Jubilant Organosys Limited | 28 |
1 |
Matrix Laboratories Limited | 105 |
1 |
MethylGene Inc. | 47 |
1 |
Mylan Laboratories Limited | 183 |
1 |
National University Corporation Chiba University | 487 |
1 |
Rohm and Haas Electronic Materials Korea Ltd. | 329 |
1 |
The United States of America as represented by the Department of Veterans Affairs | 305 |
1 |
The University of Tokyo | 4081 |
1 |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. | 69 |
1 |
Zhejiang University of Technology | 231 |
1 |
Other owners | 2 |